What is the prognosis for poorly cohesive (signet‑ring cell) gastric carcinoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Prognosis of Poorly Cohesive (Signet-Ring Cell) Gastric Carcinoma

The prognosis of poorly cohesive gastric carcinoma varies significantly based on the percentage of signet ring cells present, with pure signet ring cell carcinoma (≥90% SRC) having better survival than mixed or non-signet ring poorly cohesive subtypes, though overall prognosis remains poor compared to non-poorly cohesive gastric cancers. 1, 2

Stage-Dependent Prognostic Patterns

The prognosis of signet ring cell gastric cancer demonstrates a paradoxical relationship with disease stage:

  • Early-stage disease (Stage I-II): Signet ring cell histology shows slightly better survival compared to other gastric cancer histotypes, with improved outcomes when the tumor is confined to early stages 3

  • Advanced-stage disease (Stage III-IV): No survival differences exist between signet ring cell and other histotypes in locally advanced disease, but survival becomes significantly poorer in metastatic patients 3

  • Nodal metastases: Signet ring cell tumors demonstrate a slightly lower risk of developing lymph node metastases in early gastric cancer, though this protective effect diminishes and slightly reverses in advanced stages 3

Critical Prognostic Factor: Signet Ring Cell Percentage

The proportion of signet ring cells within poorly cohesive carcinomas is inversely related to tumor aggressiveness and represents an independent predictor of survival 1, 2:

  • Pure SRC (≥90% signet ring cells): 5-year overall survival of 58-63%, representing the most favorable poorly cohesive subtype 1, 2

  • PC-NOS/SRC (>10% but <90% signet ring cells): 5-year overall survival of 39%, with hazard ratio of 2.08 compared to pure SRC 1, 2

  • PC-NOS (≤10% signet ring cells): 5-year overall survival of 12.7-38%, representing the worst prognosis with hazard ratio of 2.38-4.32 compared to pure SRC 4, 1, 2

Molecular Profile and Survival Impact

Poorly cohesive gastric carcinoma has distinct molecular characteristics that influence prognosis 5:

  • CDH1 and RHOA mutations are remarkably more frequent in poorly cohesive carcinoma compared to non-poorly cohesive types 5

  • Among poorly cohesive subtypes, CDH1 mutations in PC-NOS (non-signet ring) are associated with extremely poor survival, while pure signet ring cell carcinoma shows better outcomes despite similar mutation profiles 5

  • Mutations in the extracellular domain 1 of CDH1 specifically correlate with poor survival in PC-NOS and combined subtypes 5

Surgical Outcomes

For carefully selected patients undergoing surgical resection 6:

  • 1-year survival: 81% in operative group versus 19.1% in nonoperative group
  • 5-year survival: 28.6% in operative group versus 1.5% in nonoperative group
  • Multivariate analysis confirms that surgical management, lower disease stage, and lower Charlson Comorbidity Index independently predict improved survival 6

Clinical Pitfalls and Diagnostic Challenges

Preoperative staging is frequently inaccurate for poorly cohesive carcinomas, particularly the PC-NOS subtype, with significant underestimation of disease extent 4. The concordance rate between preoperative clinical diagnosis and postoperative histological diagnosis is significantly lower for poorly cohesive subtypes compared to other gastric cancer types 4.

The horizontal spread pattern and non-distinguishable endoscopic appearance make accurate assessment of true tumor characteristics challenging, often delaying diagnosis until advanced stages 7.

Surgical Margin Considerations

For poorly cohesive/diffuse subtype gastric cancers, a proximal margin of 5 cm is advocated (compared to 3 cm for other histotypes) due to the infiltrative growth pattern 8.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.